Categories AlphaGraphs, Earnings, Technology
INTC Earnings: Intel posts weaker-than-expected revenue and profit for Q2
Intel Corporation (NASDAQ: INTC) Thursday reported lower-than-expected adjusted earnings and revenues for the second quarter of 2022. The semiconductor giant also provided financial guidance for the third quarter
Second-quarter revenues decreased 22% annually to $15.3 billion. The top line also missed the consensus estimates.
Adjusted earnings declined to $0.29 per share in the latest quarter from $1.36 per share in the second quarter of 2021. The latest number also fell short of expectations. On a reported basis, the company posted a net loss of $0.5 billion or $0.11 per share, compared to a profit of $5.1 billion or $1.24 per share last year.
Check this space to read management/analysts’ comments on Intel’s Q2 results
“We are being responsive to changing business conditions, working closely with our customers while remaining laser-focused on our strategy and long-term opportunities. We are embracing this challenging environment to accelerate our transformation,” said Intel’s CEO Pat Gelsinger.
Prior Performance
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
Infographic: Amazon (AMZN) Q4 2024 earnings beat estimates; sales rise 10%
E-commerce giant Amazon.com Inc. (NASDAQ: AMZN) on Thursday reported higher sales and profit for the fourth quarter of 2024. Earnings also beat analysts' estimates. Net sales increased to $187.8 billion
Philip Morris (PM) delivers strong performance in 4Q24 helped by smoke-free strength
Shares of Philip Morris International Inc. (NYSE: PM) jumped 10% on Thursday after the company delivered better-than-expected earnings results for the fourth quarter of 2024 and provided an encouraging outlook
Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report
Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in revenue. Net income attributable to shareholders was $72 million or